📰 Daniel Curran News
Daniel Curran News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Daniel Curran. Real-time updates on events, politics, business and more.
June 20, 2024
Former Shell Oil President John Hofmeister is here to weigh in on that. Oils also a hot topic at the university of dayton. The school is going green after divesting all of its fossil fuel investments. Youre going to hear exclusively from the schools president about why he is doing this and his plan to have other University Follow daytons lead as well. Yeah, bill, potentially a lot of money at stake here. Theyre doing it for ethical reasons, but theyre also under pressure, like other universities...
May 16, 2024
A teacher has the ability to change lives, elevating the minds and character of their students. And yet, they are rarely ever recognized for their dedication. With devotion that goes
February 2, 2024
Check out this week’s medical marketing news, people on the move and industry chatter.
January 8, 2024
Unique and diverse offerings often come with a host of exposures
October 6, 2023
Amy Fabris was abandoned by her father when her mother was still pregnant with her and says he brought the family nothing but misery - but now she's inherited all his land and property in Italy
September 14, 2023
Amy Fabris, 49, a dental nurse from Bournemouth, had no idea her father, Giampietro, was living in the UK until after he died in 2020 - and she was shocked to discover she was due his estate
August 26, 2023
The weather and sea conditions were fine, allowing for a short passage to the scene
June 26, 2023
Takeda TSE 4502NYSETAK today presented favorable interim results from a global pivotal Phase 3 randomized controlled openlabel crossover trial evaluating the safety and efficacy of TAK755 recombinant ADAMTS13 replacement therapy for the prophylactic treatment of congenital thrombotic thrombocytopenic purpura cTTP and pharmacokinetics PK characteristics of TAK755 as well as longterm data on TAK755 prophylaxis from a Phase 3b continuation study.
June 26, 2023
Compared to plasma-based therapies, TAK-755 (recombinant ADAMTS13) protein showed strong efficacy in a trial for cTTP, Takeda revealed.
June 25, 2023
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 25, 2023--